Board meeting outcome for approval of the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2026.
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
FDC Limited reported audited financial results for Q4 and FY2025-26. Standalone revenue from operations grew to Rs. 56,436.37 lakhs in Q4 (vs Rs. 48,200.43 lakhs in Q4 FY25), while full-year revenue stood at Rs. 212,632.72 lakhs (vs Rs. 207,011.19 lakhs in FY25), representing modest ~2.7% YoY growth. Net profit after tax for Q4 more than doubled to Rs. 10,707.03 lakhs, with full-year PAT at Rs. 28,592.34 lakhs (vs Rs. 27,362.60 lakhs), up ~4.5% YoY. An exceptional item of Rs. 2,078.91 lakhs was recognized due to incremental employee benefit obligations arising from new Labour Codes notified in November 2025. Statutory auditors BSR & Co. LLP issued an unmodified (clean) audit opinion on both standalone and consolidated results. The Board also re-appointed Cost Auditor and Tax Auditor for FY 2026-27.
The company delivered steady earnings growth with PAT up ~4.5% YoY, though revenue growth was modest. The exceptional labour code charge is non-recurring and should not affect underlying profitability. Clean audit opinion with no going concern issues is positive for shareholders.